Pharmaceutical R&D in an era of managed healthcare: using integrative teams to produce enduring competitive advantage
by Theresa K. Lant, Alan B. Eisner
International Journal of Technology Management (IJTM), Vol. 15, No. 3/4/5, 1998

Abstract: Medical technology organisations are faced with greater performance pressure in the new managed healthcare environment. In particular, pharmaceutical research and development (R&D) organisations are expected to create new and useful therapeutic treatments with greater resource constraints than ever previously experienced. We explore how pharmaceutical R&D organisations are changing the way they manage the research process in response to changing organisational and environmental constraints. This paper suggests an integrative team approach to the efficient and effective management of pharmaceutical R&D in a managed healthcare environment. We view integrative teams as an important means of increasing R&D productivity and producing competitive advantage.

Online publication date: Tue, 29-Jul-2003

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technology Management (IJTM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com